Federal opportunity · Combined Synopsis/Solicitation
ClosedNOI - A Non-Invasive Prognostic Biomarker - Circul
75N98027Q00007 · Health and Human Services, Department of · SAM.gov
Closed. Responses were due Oct 23, 2026, 9:00 AM ET.
- Responses due
- Oct 23, 2026, 9:00 AM ET
- Posted
- Oct 13, 2026
- NAICS code
- 541380 · Testing Laboratories and Services
- Set-aside
- None
- Place of performance
- Not listed
- Notice type
- Combined Synopsis/Solicitation
- Solicitation number
- 75N98027Q00007
- Official notice
- View on SAM.gov →
Open opportunities in Testing Laboratories and Services
- Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stability testing will occur under regulatory complianceHealth and Human Services, Department of · Due Nov 9, 2026 · 2 days left
- ORSC Certification and Testing ContractHealth and Human Services, Department of · Due Nov 15, 2026 · 9 days left
- A Virtual Network to Investigate the Clinical Epidemiology of Influenza and the Effectiveness of Influenza VaccinesHealth and Human Services, Department of · Due Dec 4, 2026 · 28 days left
- NOTICE of Intent to SOLE SOURCE - DS Government SolutionsHealth and Human Services, Department of · Due Jul 20, 2027 · 255 days left
- Effluent Wastewater Testing - Saginaw VAMCVeterans Affairs, Department of · Due Nov 6, 2026 · Under a day left
- AMS Designated Laboratory Meat Testing Services (ADL)Agriculture, Department of · Due Nov 6, 2026 · Under a day left
What the agency was buying
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith the format in FAR Subpart 12.6, as supplemented with additional information includedin this notice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00007. This solicitation is issued as a Notice ofIntent (NOI) for a non-competitive combined synopsis/solicitation to award a contract orpurchase order without providing for full and open competition (including brand-name, ifapplicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to University of Alabama at Birmingham, 701 S 20th Street, Birmingham, AL 35294-0001-0001, for research support to develop and
Show the full description · 121 more wordsShow less
validate circulating cell-free DNA (cfDNA) as a blood-based biomarker of chlorine-induced acute lung injury, using the Matalon Laboratory's sole-source validated murine chlorine inhalation injury model, established mechanistic expertise, access to its actively enrolling aspiration pneumonitis biorepository (human proxy cohort), existing collaborative infrastructure with the NHLBI Laboratory of Precision Omics, and continuity with peer-reviewed federal funding (NIH R01 HL031197). These capabilities are not available from any other source and are essential to the project's feasibility. (iii)The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv)The associated NAICS code is 541380, Testing Laboratories and Services, and the small business size standard is $19.0 million.
This requirement is not set aside for small business.
From the official notice on SAM.gov.